| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3390/IJMS20030739 |
| P953 | full work available at URL | https://www.mdpi.com/1422-0067/20/3/739 |
| P932 | PMC publication ID | 6387410 |
| P698 | PubMed publication ID | 30744173 |
| P50 | author | Constantin Caruntu | Q56191507 |
| Maria-Isabela Sarbu | Q61087877 | ||
| Monica Neagu | Q37839701 | ||
| P2093 | author name string | Carolina Constantin | |
| Constantin Caruntu | |||
| Clara Matei | |||
| Cristina-Iulia Mitran | |||
| Madalina-Irina Mitran | |||
| Maria-Isabela Sarbu | |||
| Mircea Tampa | |||
| Simona-Roxana Georgescu | |||
| P2860 | cites work | Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling | Q24647357 |
| Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris | Q24676186 | ||
| Recent advances in understanding psoriasis | Q26751223 | ||
| The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing | Q27687800 | ||
| T Helper Cell Subsets in Clinical Manifestations of Psoriasis | Q28069848 | ||
| Th1/Th2 cells | Q28138975 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Regulation of interferon-gamma during innate and adaptive immune responses | Q28256001 | ||
| IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis | Q28268370 | ||
| Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. | Q54221095 | ||
| The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis. | Q54261770 | ||
| The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. | Q54956609 | ||
| The potential role of Th17 lymphocytes in patients with psoriasis. | Q55077651 | ||
| Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment. | Q55115632 | ||
| AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model | Q57194204 | ||
| CD8 T Cells and IFN-γ Emerge as Critical Players for Psoriasis in a Novel Model of Mouse Psoriasiform Skin Inflammation | Q58235912 | ||
| Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation | Q59309381 | ||
| Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis | Q60683089 | ||
| Phenotypic changes of lymphocyte populations in psoriasiform dermatitis animal model. | Q64944673 | ||
| Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides | Q80947270 | ||
| Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity | Q82227244 | ||
| Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris | Q83178735 | ||
| Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin | Q84307121 | ||
| TGFβ1, an epidermal controller of skin dendritic cell homeostasis | Q85855950 | ||
| MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation | Q88660923 | ||
| Is the humoral immunity dispensable for the pathogenesis of psoriasis? | Q88948467 | ||
| The role of regulatory T cells and anti-inflammatory cytokines in psoriasis | Q95510208 | ||
| IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells. | Q50585381 | ||
| Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis. | Q51246866 | ||
| Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity. | Q51746554 | ||
| Targeting IL-23 in psoriasis: current perspectives. | Q52695350 | ||
| Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. | Q52890471 | ||
| Human ß-Defensin 3 and Its Mouse Ortholog Murine ß-Defensin 14 Activate Langerhans Cells and Exacerbate Psoriasis-Like Skin Inflammation in Mice. | Q53137209 | ||
| [Immunopathology of psoriasis: from bench to bedside]. | Q53138245 | ||
| Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. | Q53576190 | ||
| Novel mutations in IL-10 promoter region -377 (C>T), -150 (C>A) and their association with psoriasis in the saudi population. | Q54172110 | ||
| Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. | Q54194408 | ||
| An increased proportion of circulating Th22 and Tc22 cells in psoriasis. | Q54198175 | ||
| Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide | Q29619485 | ||
| A New Kid on the Block: IL-10+ Regulatory B Cells and a Possible Role In Psoriasis | Q33403761 | ||
| Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells | Q33598026 | ||
| PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines. | Q33626689 | ||
| Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10 | Q33646955 | ||
| Tristetraprolin expression by keratinocytes controls local and systemic inflammation. | Q33752343 | ||
| TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. | Q33860715 | ||
| Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation | Q33897776 | ||
| Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab | Q34199603 | ||
| Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. | Q34474419 | ||
| The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat | Q34505900 | ||
| RORγ antagonists and inverse agonists: a patent review | Q34540327 | ||
| Pathologic patterns of interleukin 10 expression--a review | Q34667904 | ||
| Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity | Q34945351 | ||
| Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. | Q35563885 | ||
| Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy | Q35680472 | ||
| Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation | Q36350856 | ||
| An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia | Q36398788 | ||
| Update on psoriasis immunopathogenesis and targeted immunotherapy. | Q36445919 | ||
| Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice. | Q36580091 | ||
| Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling | Q36595887 | ||
| The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases | Q36984717 | ||
| Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation | Q37176336 | ||
| Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis | Q37179608 | ||
| CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity | Q37191197 | ||
| Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis | Q37306962 | ||
| Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. | Q37322356 | ||
| Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset | Q37372754 | ||
| Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis | Q37460263 | ||
| Overexpression of Glucocorticoid-induced Leucine Zipper (GILZ) increases susceptibility to Imiquimod-induced psoriasis and involves cutaneous activation of TGF-β1. | Q37488232 | ||
| A role for TGFbeta signaling in the pathogenesis of psoriasis | Q37587746 | ||
| Prokineticin 2 Plays a Pivotal Role in Psoriasis | Q37604630 | ||
| Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. | Q37632469 | ||
| CCN1 promotes IL-1β production in keratinocytes by activating p38 MAPK signaling in psoriasis | Q37683778 | ||
| Th17 and Th22 cells in psoriatic arthritis and psoriasis | Q37689670 | ||
| Bimodal immune activation in psoriasis | Q38151778 | ||
| Interleukin-22: a likely target for treatment of autoimmune diseases | Q38177958 | ||
| Proteomics focusing on immune markers in psoriatic arthritis. | Q38230695 | ||
| Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis | Q38412949 | ||
| Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions | Q38673368 | ||
| The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis. | Q38707588 | ||
| Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy | Q38707920 | ||
| HIF-1--a big chapter in the cancer tale | Q38794544 | ||
| Immunopathology alters Th17 cell glucocorticoid sensitivity | Q38959155 | ||
| Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers | Q38991358 | ||
| ACKR2: Nature's Decoy Receptor Lures Unsuspecting Chemokines in Psoriasis | Q39051842 | ||
| Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice | Q39153776 | ||
| Overexpression and potential roles of NRIP1 in psoriasis | Q39318754 | ||
| Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications | Q39376982 | ||
| Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2. | Q39635125 | ||
| Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis | Q39666116 | ||
| Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis | Q40216414 | ||
| The interferon receptors | Q41518949 | ||
| The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis | Q41620801 | ||
| Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis | Q41675873 | ||
| Exopolysaccharides from Cyanobacterium aponinum from the Blue Lagoon in Iceland increase IL-10 secretion by human dendritic cells and their ability to reduce the IL-17+RORγt+/IL-10+FoxP3+ ratio in CD4+ T cells | Q41700360 | ||
| Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis | Q41828492 | ||
| A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. | Q42042837 | ||
| CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. | Q42355640 | ||
| Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model | Q42369054 | ||
| Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris | Q43812130 | ||
| Polymorphisms in the TNF-α and IL-10 gene promoters and risk of psoriasis and correlation with disease severity | Q44987409 | ||
| Serum interferon-gamma is a psoriasis severity and prognostic marker | Q46215970 | ||
| Capsaicin: Friend or Foe in Skin Cancer and Other Related Malignancies? | Q47162516 | ||
| MicroRNA-146 and cell trauma downregulate expression of the psoriasis-associated atypical chemokine receptor ACKR2. | Q47253178 | ||
| Biological therapies in psoriasis - revisited | Q47601468 | ||
| Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris | Q47795365 | ||
| Scanning the Immunopathogenesis of Psoriasis | Q48278167 | ||
| The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function. | Q49391905 | ||
| Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints | Q50099588 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| inflammation | Q101991 | ||
| psoriasis | Q179945 | ||
| immunity | Q182581 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 739 | |
| P577 | publication date | 2019-01-01 | |
| 2019-02-10 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Advances in Understanding the Immunological Pathways in Psoriasis | |
| P478 | volume | 20 |
| Q92593942 | Characteristics of psoriasis vulgaris in China: a prospective cohort study protocol |
| Q90745225 | Current Developments in the Immunology of Psoriasis |
| Q91829705 | Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo |
| Q96134668 | Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances |
| Q91671642 | Reinforcing involvement of NK cells in psoriasiform dermatitis animal model |
| Q93176443 | Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation |
Search more.